ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,182,404 | -7.6% | 798,922 | +0.5% | 0.00% | – |
| Q2 2023 | $1,280,339 | -49.7% | 795,241 | -9.3% | 0.00% | -100.0% |
| Q1 2023 | $2,542,906 | -12.0% | 876,864 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $2,889,359 | -10.6% | 880,902 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $3,233,000 | -52.2% | 855,295 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $6,761,000 | -12.5% | 868,005 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $7,730,000 | -43.0% | 831,952 | -3.3% | 0.00% | -50.0% |
| Q4 2021 | $13,558,000 | -10.2% | 860,257 | +2.0% | 0.00% | -33.3% |
| Q3 2021 | $15,094,000 | +11.3% | 843,249 | -3.3% | 0.00% | +50.0% |
| Q2 2021 | $13,557,000 | +5.2% | 871,807 | -2.8% | 0.00% | 0.0% |
| Q1 2021 | $12,882,000 | -27.9% | 897,114 | -1.4% | 0.00% | -33.3% |
| Q4 2020 | $17,862,000 | +53.5% | 909,992 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $11,633,000 | +2.5% | 897,594 | +15.3% | 0.00% | 0.0% |
| Q2 2020 | $11,345,000 | +92.1% | 778,680 | +12.2% | 0.00% | +50.0% |
| Q1 2020 | $5,905,000 | -46.7% | 693,990 | +3.1% | 0.00% | 0.0% |
| Q4 2019 | $11,086,000 | +21.2% | 673,087 | +3.9% | 0.00% | 0.0% |
| Q3 2019 | $9,149,000 | -11.7% | 647,907 | +25.8% | 0.00% | 0.0% |
| Q2 2019 | $10,361,000 | -50.4% | 515,232 | -2.0% | 0.00% | -60.0% |
| Q1 2019 | $20,891,000 | +15.2% | 525,571 | +0.7% | 0.01% | 0.0% |
| Q4 2018 | $18,128,000 | -16.3% | 521,809 | -0.4% | 0.01% | 0.0% |
| Q3 2018 | $21,670,000 | +18.6% | 524,072 | +5.4% | 0.01% | 0.0% |
| Q2 2018 | $18,278,000 | +19.7% | 497,371 | +27.1% | 0.01% | +25.0% |
| Q1 2018 | $15,265,000 | +192.0% | 391,436 | +35.6% | 0.00% | +300.0% |
| Q4 2017 | $5,227,000 | +10.1% | 288,773 | +0.6% | 0.00% | 0.0% |
| Q3 2017 | $4,749,000 | +13.5% | 286,973 | -3.9% | 0.00% | 0.0% |
| Q2 2017 | $4,183,000 | -23.7% | 298,739 | +12.0% | 0.00% | -50.0% |
| Q1 2017 | $5,480,000 | +48.5% | 266,674 | +2.6% | 0.00% | +100.0% |
| Q4 2016 | $3,690,000 | -31.3% | 259,895 | +3.4% | 0.00% | -50.0% |
| Q3 2016 | $5,374,000 | -0.8% | 251,244 | +4.4% | 0.00% | 0.0% |
| Q2 2016 | $5,419,000 | +50.3% | 240,735 | +27.1% | 0.00% | +100.0% |
| Q1 2016 | $3,605,000 | -27.0% | 189,459 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $4,940,000 | -14.0% | 187,073 | +2.4% | 0.00% | 0.0% |
| Q3 2015 | $5,745,000 | +29.0% | 182,734 | +116.6% | 0.00% | +100.0% |
| Q2 2015 | $4,452,000 | +53.2% | 84,384 | +20.7% | 0.00% | 0.0% |
| Q1 2015 | $2,906,000 | +87.0% | 69,912 | +20.4% | 0.00% | – |
| Q4 2014 | $1,554,000 | – | 58,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |